Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane R Parnes

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Hybridoma (2005)|June 27, 2006
A unique CD72 epitope suggests a potential interaction with Fc gamma RII/CD32 on B lineage lymphocytesYoshio Yamashita, Hyewon Phee, Kim-Sue R S Tudor, et al.
Journal of Leukocyte Biology|January 15, 2003
OX52 is the rat homologue of CD6: evidence for an effector function in the regulation of CD5 phosphorylationMónica A A Castro, Raquel J Nunes, Marta I Oliveira, et al.
Pulmonary Therapy|April 26, 2025
Tezepelumab can Restore Normal Lung Function in Patients with Severe, Uncontrolled Asthma: Pooled Results from the PATHWAY and NAVIGATOR StudiesIan D Pavord, Christopher E Brightling, Stephanie Korn, et al.
Clinical and Translational Science|October 2, 2025
Safety, Pharmacokinetics, and Immunogenicity of Astegolimab, an Anti-ST2 Monoclonal Antibody, in Randomized, Phase I Clinical StudiesWenhui Zhang, Dorothy Cheung, Alice Fong, et al.
International Immunology|June 1, 2002
CD6: expression during development, apoptosis and selection of human and mouse thymocytesNora G Singer, David A Fox, Tariq M Haqqi, et al.
Arthritis and Rheumatism|September 30, 2008
Modulation of peripheral B cell tolerance by CD72 in a murine modelDaniel Hsieh-Hsin Li, Monte M Winslow, Thai M Cao, et al.
The Lancet. Respiratory Medicine|July 13, 2021
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trialSarah Diver, Latifa Khalfaoui, Claire Emson, et al.
International Immunology|August 23, 2005
Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartmentAtsushi Kumanogoh, Takashi Shikina, Chie Watanabe, et al.
NEJM Evidence|February 6, 2024
Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe AsthmaLars H Nordenmark, Åsa Hellqvist, Claire Emson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
Extracellular isoforms of CD6 generated by alternative splicing regulate targeting of CD6 to the immunological synapseMónica A A Castro, Marta I Oliveira, Raquel J Nunes, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Hybridoma (2005)|June 27, 2006
A unique CD72 epitope suggests a potential interaction with Fc gamma RII/CD32 on B lineage lymphocytesYoshio Yamashita, Hyewon Phee, Kim-Sue R S Tudor, et al.
Journal of Leukocyte Biology|January 15, 2003
OX52 is the rat homologue of CD6: evidence for an effector function in the regulation of CD5 phosphorylationMónica A A Castro, Raquel J Nunes, Marta I Oliveira, et al.
Pulmonary Therapy|April 26, 2025
Tezepelumab can Restore Normal Lung Function in Patients with Severe, Uncontrolled Asthma: Pooled Results from the PATHWAY and NAVIGATOR StudiesIan D Pavord, Christopher E Brightling, Stephanie Korn, et al.
Clinical and Translational Science|October 2, 2025
Safety, Pharmacokinetics, and Immunogenicity of Astegolimab, an Anti-ST2 Monoclonal Antibody, in Randomized, Phase I Clinical StudiesWenhui Zhang, Dorothy Cheung, Alice Fong, et al.
International Immunology|June 1, 2002
CD6: expression during development, apoptosis and selection of human and mouse thymocytesNora G Singer, David A Fox, Tariq M Haqqi, et al.
Arthritis and Rheumatism|September 30, 2008
Modulation of peripheral B cell tolerance by CD72 in a murine modelDaniel Hsieh-Hsin Li, Monte M Winslow, Thai M Cao, et al.
The Lancet. Respiratory Medicine|July 13, 2021
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trialSarah Diver, Latifa Khalfaoui, Claire Emson, et al.
International Immunology|August 23, 2005
Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartmentAtsushi Kumanogoh, Takashi Shikina, Chie Watanabe, et al.
NEJM Evidence|February 6, 2024
Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe AsthmaLars H Nordenmark, Åsa Hellqvist, Claire Emson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
Extracellular isoforms of CD6 generated by alternative splicing regulate targeting of CD6 to the immunological synapseMónica A A Castro, Marta I Oliveira, Raquel J Nunes, et al.
Pageof 5